TM
ABBV icon

TigerOak Management’s AbbVie ABBV Stock Holding History

TigerOak Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$862K Buy
3,962
+7
+0.2% +$1.55K 0.27% 50
2025
Q4 		$904K Hold
3,955
– – 0.28% 52
2025
Q3 		$916K Hold
3,955
– – 0.28% 51
2025
Q2 		$734K Hold
3,955
– – 0.25% 58
2025
Q1 		$829K Hold
3,955
– – 0.32% 48
2024
Q4 		$703K Buy
+3,955
New +$727K 0.26% 55

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TigerOak Management's ABBV Position: Q1 2026 in Review

TigerOak Management increased its AbbVie (ABBV) stake by 0.18% in Q1 2026, buying an estimated $1.55K and bringing the position to 3,962 shares worth $862K. The position accounts for 0.27% of the portfolio, ranked #50.

TigerOak Management first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $916K in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • TigerOak Management held 3,962 shares of AbbVie worth $862K as of Q1 2026.
  • TigerOak Management bought 7 AbbVie shares in Q1 2026, an estimated $1.55K.
  • AbbVie made up 0.27% of TigerOak Management's portfolio in Q1 2026, its #50 holding.
  • TigerOak Management first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • TigerOak Management's AbbVie position peaked at $916K in Q3 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on TigerOak Management's 13F filing for Q1 2026, filed 21 Apr 2026.